Literature DB >> 6301988

Component(s) of Sendai virus that can induce interferon in mouse spleen cells.

Y Ito, Y Hosaka.   

Abstract

To identify the active component of Sendai virus that induces interferon in mouse spleen cells, infectious and noninfectious viruses, envelope particles derived from them, and isolated hemagglutinin-neuraminidase (HN) glycoproteins were examined for interferon induction. The interaction between membranous structures containing Sendai virus HN glycoprotein and the receptors on the cell surface was shown to be sufficient for interferon induction in mouse spleen cells, suggesting that the actual inducer of interferon in mouse spleen cells is the HN glycoprotein of Sendai virus. When mouse spleen cells were stimulated in vitro with Sendai virus grown in eggs or LLC-MK2 cells or with membranous structures containing glycoproteins obtained from these viruses, interferon could be detected in the culture fluid. Furthermore, isolated HN glycoprotein per se could induce interferon in the cells. A linear correlation was found between the titer of interferon induced and the hemagglutinating activity of the membranous structure containing the HN glycoprotein. It was concluded from these findings that HN glycoprotein was the active component of Sendai virus responsible for interferon induction in mouse spleen cells and that viral RNA and F glycoprotein were not required. The results also showed that the interaction between HN glycoprotein and receptors on the cell surface triggered production of type I interferon (IFN-alpha and IFN-beta). Although when Sendai virus was incubated at 56 degrees C for 5 min it lost its hemolytic and hemagglutinating activities, it induced a considerable amount of interferon in the culture fluid of mouse spleen cells. The interferon-inducing ability of heat-inactivated virus could be absorbed with mouse spleen cells but not with sheep erythrocytes or mouse erythrocytes, indicating that the inactivated virus retained ability to bind to mouse lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301988      PMCID: PMC348058          DOI: 10.1128/iai.39.3.1019-1023.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  An efficient method for reassembly of fusogenic Sendai virus envelopes after solubilization of intact virions with Triton X-100.

Authors:  D J Volsky; A Loyter
Journal:  FEBS Lett       Date:  1978-08-15       Impact factor: 4.124

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The mechanism of interferon induction in mouse spleen cells stimulated with HVJ.

Authors:  Y Ito; Y Nishiyama; K Shimokata; I Nagata; H Takeyama; A Kunii
Journal:  Virology       Date:  1978-07-01       Impact factor: 3.616

4.  Studies on the pathogenicity of human-origin parainfluenza virus in the brain of mice.

Authors:  K Shimokata
Journal:  Microbiol Immunol       Date:  1978       Impact factor: 1.955

5.  Production of interferon-like substance by mouse spleen cells through contact with BHK cells persistently infected with HVJ.

Authors:  Y Ito; Y Kimura; I Nagata; A Kunii
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

6.  Artificial assembly of envelope particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion factors from envelopes solubilized by Nonidet P40.

Authors:  Y Hosaka; Y K Shimizu
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

7.  Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component.

Authors:  Y Hosaka; Y Fukami; Y Yasuda; J A Bonilla
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

8.  Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins.

Authors:  Y Hosaka
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Purification of Sendai virions with glutaraldehyde-treated red blood cells.

Authors:  Y Hosaka; Y Hosokawa
Journal:  Intervirology       Date:  1977       Impact factor: 1.763

  9 in total
  7 in total

1.  Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats.

Authors:  Peng Zhou; Mary Tachedjian; James W Wynne; Victoria Boyd; Jie Cui; Ina Smith; Christopher Cowled; Justin H J Ng; Lawrence Mok; Wojtek P Michalski; Ian H Mendenhall; Gilda Tachedjian; Lin-Fa Wang; Michelle L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

2.  The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; Y Nagai
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

3.  Cell-mediated cytotoxicity against targets bearing Sendai virus glycoproteins in the absence of viral infection.

Authors:  T F Abidi; T D Flanagan
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

4.  Interferon induction by adenovirus type 12: stimulatory function of early region 1A.

Authors:  M I Toth; B Arya; R Pusztai; K Shiroki; I Beladi
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

5.  Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes.

Authors:  I Kurane; F A Ennis
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

Review 6.  Induction of interferon by virus glycoprotein(s) in lymphoid cells through interaction with the cellular receptors via lectin-like action: an alternative interferon induction mechanism.

Authors:  Y Ito
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  More than one component of the Newcastle disease virus particle is capable of interferon induction.

Authors:  K Wertz; M Büttner; A Mayr; O R Kaaden
Journal:  Vet Microbiol       Date:  1994-04       Impact factor: 3.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.